Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis

Lozano Calderón, Santiago A; Garbutt, Cassandra; Kim, Jason; Lietz, Christopher E; Chen, Yen-Lin; Bernstein, Karen; Chebib, Ivan; Nielsen, G Petur; Deshpande, Vikram; Rubio, Renee; Wang, Yaoyu E; Quackenbush, John; Delaney, Thomas; Raskin, Kevin; Schwab, Joseph; Cote, Gregory; Spentzos, Dimitrios
September 2019
Clinical Orthopaedics & Related Research;Sep2019, Vol. 477 Issue 9, p2114
Academic Journal
journal article
Background: MicroRNAs are small, noncoding RNAs that regulate the expression of posttranslational genes. The presence of some specific microRNAs has been associated with increased risk of both local recurrence and metastasis and worse survival in patients with osteosarcoma. Pathologic fractures in osteosarcoma are considered to be more the manifestation of a neoplasm with a more aggressive biological behavior than the cause itself of worse prognosis. However, this has not been proved at the biological or molecular level. Currently, there has not been a microRNA profiling study of patients who have osteosarcoma with and without pathologic fractures that has described differences in terms of microRNA profiling between these two groups and their correlation with biologic behavior.Questions/purposes: (1) In patients with osteosarcoma of the extremities, how do the microRNA profiles of those with and without pathologic fractures compare? (2) What relationship do microRNAs have with local recurrence, risk of metastasis, disease-specific survival, and overall survival in osteosarcoma patients with pathologic fractures?Methods: Between 1994 and 2013, 217 patients were diagnosed and treated at our institution for osteosarcoma of the extremities. Patients were excluded if (1) they underwent oncologic resection of the osteosarcoma at an outside institution (two patients) or (2) they were diagnosed with an extraskeletal osteosarcoma (29 patients) or (3) they had less than 1 year of clinical follow-up and no oncologic outcome (local recurrence, metastasis, or death) (four patients). A total of 182 patients were eligible. Of those, 143 were high-grade osteosarcomas. After evaluation of tumor samples before chemotherapy treatment, a total of 80 consecutive samples were selected for sequencing. Demographic and clinical comparison between the sequenced and non-sequenced patients did not demonstrate any differences, confirming that both groups were comparable. Diagnostic samples from the extremities of 80 patients with high-grade extremity osteosarcomas who had not yet received chemotherapy underwent microRNA sequencing for an ongoing large-scale osteosarcoma genome profiling project at our institution. Six samples were removed after a second look by a musculoskeletal pathologist who verified cellularity and quality of samples to be sequenced, leaving a total of 74 patients. Of these, two samples were removed as they were confirmed to be pelvic tumors in a second check after sequencing. The final study sample was 72 patients (11 patients with pathologic fractures and 61 without). Sequencing data were correlated with fractures and local recurrence, risk of metastasis, disease-specific survival, and overall survival through Kaplan-Meier analyses.Results: Several microRNAs were expressed differently between the two groups. Among the markers with the highest differential expression (edgeR and DESeq algorithms), Hsa-mIR 656-3p, hsa-miR 493-5p, and hsa-miR 381-3p were upregulated in patients with pathologic fractures, whereas hsa-miR 363, hsa-miR 885-5p, and has-miR 20b-5p were downregulated. The highest differential expression fracture and nonfracture-associated microRNA markers also distinguished groups of patients with different metastasis risk, a well as different disease-specific and overall survival. Furthermore, the profile of pathologic fractures demonstrated a higher differential expression for microRNA markers that were previously associated with a higher risk of metastasis and lower survival rates in patients with osteosarcoma.Conclusions: In patients who have osteosarcoma, the microRNA profiles of those with pathologic fractures are different than of patients without pathologic fractures. The highest differential expression mircroRNA molecules in patients with pathologic fractures predict also higher risk of metastatic disease as well as worse disease-specific survival and overall survival. Furthermore, we found higher differential expression of microRNAs in the pathologic fracture group previously associated with poor prognosis. The higher risk of metastasis and poorer overall survival in patients with pathologic fractures is inherent to tumor aggressive biologic behavior. It is plausible that the fracture itself is not the direct cause of worse prognosis but another manifestation of tumor biologic aggressiveness. Identification of these molecules through liquid biopsies may help to determine which patients may benefit from surgery before fractures occur. The same technology can be applied to identify patterns of response to conventional chemotherapy, assisting in more specific and accurate systemic therapy.Level Of Evidence Level: III, prognostic study.


Related Articles

  • Profile of MicroRNA Expression in Brain Tumors of Different Malignancy. Koshkin, F.; Chistyakov, D.; Nikitin, A.; Konovalov, A.; Potapov, A.; Usachyov, D.; Pitskhelauri, D.; Kobyakov, G.; Shishkina, L.; Chekhonin, V. // Bulletin of Experimental Biology & Medicine;Oct2014, Vol. 157 Issue 6, p794 

    The expression profiles of 10 mature microRNA (7, 10a, 17, 20a, 21, 23a, 26a, 137, 222) in biopsy specimens of gliomas of different malignancy were studied by the real time PCR with SYBR Green I fluorescent stain. The expression of microRNA-21 increased significantly, while that of microRNA-137...

  • MicroRNA-186-5p Inhibits Proliferation And Metastasis Of Esophageal Cancer By Mediating HOXA9. Xu, Changqin; Li, Bin; Zhao, Shulei; Jin, Bingjie; Jia, Ruzhen; Ge, Jian; Xu, Hongwei // OncoTargets & Therapy;Oct2019, Vol. 12, p8905 

    aim of this study was to investigate the expression characteristics of microRNA-186-5p in esophageal cancer (ECa) and its correlation with clinical progression and prognosis, and to further explore its underlying mechanisms. Methods: Real-time quantitative PCR (qRT-PCR) was used to detect...

  • MicroRNA-124 functions as a tumor suppressor and indicates prognosis in human osteosarcoma. GANG HAN; YAN WANG; WENZHI BI; JINPENG JIA; WEI WANG // Experimental & Therapeutic Medicine;2015, Vol. 9 Issue 3, p679 

    MicroRNA-124 (miR-124) has been demonstrated to be downregulated in numerous human malignancies and correlated with tumor progression. However, its expression and clinical significance in osteosarcoma remains unclear. Thus, the aim of the present study was to explore the effects of miR-124 in...

  • MicroRNA-10a-5p and microRNA-34c-5p in laryngeal epithelial premalignant lesions: differential expression and clinicopathological correlation. Hu, Yanping; Liu, Honggang // European Archives of Oto-Rhino-Laryngology;Feb2015, Vol. 272 Issue 2, p391 

    This study was to analyze the dys-regulation of microRNA-10a-5p and microRNA-34c-5p and their correlations with clinicopathological characteristics of laryngeal epithelial premalignant lesions (LEPL). Quantitative real-time polymerase chain reaction was performed to detect the expression of...

  • MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma. Shi-hong Xu; Yong-liang Yang; Shu-mei Han; Zong-hui Wu // World Journal of Surgical Oncology;2014, Vol. 12 Issue 1, p1 

    Background The purpose of the present study was to examine the expression levels of microRNA-9 (miR- 9) in osteosarcoma tissues and normal bone tissues, and investigate the relationships between miR-9 expression, clinicopathological features and the prognosis of patients with osteosarcoma....

  • microRNA-363 plays a tumor suppressive role in osteosarcoma by directly targeting MAP2K4. Xueqin Li; Xinsheng Liu; Jun Fang; Huazhuang Li; Jingchun Chen // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 11, p20157 

    Abnormal expression of microRNAs plays important functions in osteosarcoma. The aim of this study was to investigate expression, functions and molecular mechanisms of microRNA-363 in osteosarcoma. Quantitative Real-time PCR was used to detect the expression level of microRNA-363 in osteosarcoma...

  • Molecular Profiling of Aggressive Lymphomas. Rossi, Maura; Laginestra, Maria Antonella; Gazzola, Anna; Sapienza, Maria Rosaria; Pileri, Stefano A.; Piccaluga, Pier Paolo // Advances in Hematology;2012, p1 

    In the last years, several studies of molecular profiling of aggressive lymphomas were performed. In particular, it was shown that DLBCL can be distinguished in two different entities according to GEP. Specifically, ABC and GCB subtypes were characterized by having different pathogenetic and...

  • Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer. Cascione, Luciano; Gasparini, Pierluigi; Lovat, Francesca; Carasi, Stefania; Pulvirenti, Alfredo; Ferro, Alfredo; Alder, Hansjuerg; He, Gang; Vecchione, Andrea; Croce, Carlo M.; Shapiro, Charles L.; Huebner, Kay // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Triple negative breast cancer (TNBC) is a heterogeneous disease at the molecular, pathologic and clinical levels. To stratify TNBCs, we determined microRNA (miRNA) expression profiles, as well as expression profiles of a cancer-focused mRNA panel, in tumor, adjacent non-tumor (normal) and lymph...

  • Determination of the apoptotic index in osteosarcoma tissue and its relationship with patients prognosis. Xing Wu; Biao Cheng; Zheng-dong Cai; Lie-ming Lou // Cancer Cell International;2013, Vol. 13 Issue 1, p1 

    Background: Nowadays it remains a controversial issue whether a correlation exists between the apoptosis rate of tumor tissue and the prognosis of the patients. We aimed to explore the prognostic significance of apoptosis index of human osteosarcoma tissue. Methods: The technique of terminal DNA...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics